Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$63.70
-1.23%
Mkt Cap $8.10B
Mkt Cap
$8.10B
P/E
25.86
Fwd P/E
7.47
P/S
5.80
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$63.70
-1.23%
Mkt Cap $8.10B
Mkt Cap
$8.10B
P/E
25.86
Fwd P/E
7.47
P/S
5.80
Rev TTM
—
EPS TTM
$2.49